Compugen Ltd.
C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
Last updated:
Abstract:
This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
14 May 2019
Issue date:
2 Jan 2020